Breaking News Instant updates and real-time market news.

2021-03-03 04:55:00 KAI Kadant $176.26 / -5.62 (-3.09%) 04:55 03/03/21 03/03 04:55 03/03/21 04:55	Kadant management to meet virtually with Barrington Virtual Meetings to be held on March 2-3 hosted by Barrington.	03 Mar
KAI Kadant $176.26 / -5.62 (-3.09%) 02/19/21 DA Davidson Kadant price target raised to $140 from $115 at DA Davidson 02/19/21 Barrington Kadant upgraded to Outperform from Market Perform at Barrington 07/27/20 DA Davidson Kadant price target raised to $105 from $75 at DA Davidson 05/28/20 Barrington Kadant downgraded to Market Perform from Outperform at Barrington

2021-03-03 04:55:00

KAI

Kadant

$176.26 / -5.62 (-3.09%)

04:55

03/03/21

03/03

04:55

03/03/21

04:55

Kadant management to meet virtually with Barrington

Virtual Meetings to be held on March 2-3 hosted by Barrington.

03
Mar

KAI Kadant

$176.26 / -5.62 (-3.09%)

02/19/21 DA Davidson: Kadant price target raised to $140 from $115 at DA Davidson

02/19/21 Barrington: Kadant upgraded to Outperform from Market Perform at Barrington

07/27/20 DA Davidson: Kadant price target raised to $105 from $75 at DA Davidson

05/28/20 Barrington: Kadant downgraded to Market Perform from Outperform at Barrington

TODAY'S FREE FLY STORIES

Conference/Events	Federal Reserve Bank of Atlanta president participates in virtual event » 15:05 04/13/21 04/13 15:05 04/13/21 15:05 Atlanta Federal Reserve… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Mesabi Trust options imply 4.0% move in share price post-earnings » 15:04 04/13/21 04/13 15:04 04/13/21 15:04 MSB Mesabi Trust $35.23 / +2.65 (+8.13%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Teleperformance price target raised to EUR 370 from EUR 350 at Morgan Stanley » 15:03 04/13/21 04/13 15:03 04/13/21 15:03 TLPFY Teleperformance $194.94 / +4.2 (+2.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLPFY Teleperformance $194.94 / +4.2 (+2.20%) 14:29 Today JPMorgan Teleperformance price target raised to EUR 370 from EUR 340 at JPMorgan 05:04 Today AlphaValue Teleperformance upgraded to Add from Reduce at AlphaValue 03/17/21 Morgan Stanley Teleperformance price target raised to EUR 350 from EUR 340 at Morgan Stanley 03/01/21 Deutsche Bank Teleperformance price target raised to EUR 355 from EUR 345 at Deutsche Bank
Recommendations	Repsol price target raised to EUR 10.90 from EUR 10 at Morgan Stanley » 15:02 04/13/21 04/13 15:02 04/13/21 15:02 REPYY Repsol $12.15 / +0.04 (+0.33%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research REPYY Repsol $12.15 / +0.04 (+0.33%) 06:56 Today JPMorgan Repsol upgraded to Neutral on balanced risk/reward at JPMorgan 05:13 Today Exane BNP Paribas Repsol downgraded to Underperform from Neutral at Exane BNP Paribas 04/12/21 JPMorgan Repsol upgraded to Neutral from Underweight at JPMorgan 03/12/21 Deutsche Bank Repsol initiated with a Buy at Deutsche Bank
Recommendations	OMV AG price target raised to EUR 49 from EUR 44 at Morgan Stanley » 15:02 04/13/21 04/13 15:02 04/13/21 15:02 OMVKY OMV AG $50.74 / +0.66 (+1.32%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research OMVKY OMV AG $50.74 / +0.66 (+1.32%) 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out OMVKY OMV AG $50.74 / +0.66 (+1.32%) 14:28 Today JPMorgan OMV AG price target raised to EUR 52 from EUR 50 at JPMorgan 03/12/21 Deutsche Bank OMV AG initiated with a Buy at Deutsche Bank 03/03/21 JPMorgan OMV AG price target raised to EUR 50 from EUR 44 at JPMorgan 02/16/21 UBS OMV AG upgraded to Buy from Neutral at UBS

Recommendations	Galp Energia price target raised to EUR 10.50 from EUR 10.20 at Morgan Stanley » 15:02 04/13/21 04/13 15:02 04/13/21 15:02 GLPEY Galp Energia $5.65 / -0.085 (-1.48%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GLPEY Galp Energia $5.65 / -0.085 (-1.48%) 03/05/21 Goldman Sachs Galp Energia upgraded to Buy from Neutral at Goldman Sachs 02/23/21 Credit Suisse Galp Energia price target lowered to EUR 13 from EUR 14 at Credit Suisse 01/21/21 Jefferies Galp Energia initiated with a Hold at Jefferies 01/15/21 JPMorgan Galp Energia price target lowered to EUR 11 from EUR 11.50 at JPMorgan
Recommendations	Covestro price target raised to EUR 67 from EUR 60 at Morgan Stanley » 15:00 04/13/21 04/13 15:00 04/13/21 15:00 COVTY Covestro $33.75 / +0.3 (+0.90%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research COVTY Covestro $33.75 / +0.3 (+0.90%) 03/19/21 UBS Covestro price target raised to EUR 50 from EUR 46 at UBS 03/08/21 Citi Covestro downgraded to Sell from Buy at Citi 02/25/21 Berenberg Covestro price target raised to EUR 65 from EUR 60 at Berenberg 02/25/21 Societe Generale Covestro price target raised to EUR 74 from EUR 65 at Societe Generale
Recommendations	AdaptHealth key leadership remains in place, says RBC Capital » 15:00 04/13/21 04/13 15:00 04/13/21 15:00 AHCO AdaptHealth / + After AdaptHealth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AHCO AdaptHealth / + 09:50 Today AdaptHealth places co-CEO Luke McGee on unpaid leave 09:49 Today AdaptHealth board: Denmark athorities formally charge co-CEO with tax fraud 01/04/21 AdaptHealth falls 5% to $34.00 per share after equity offering 12/01/20 AdaptHealth, AeroCare combination to operate under AdaptHealth name AHCO AdaptHealth / + 12:14 Today Baird AdaptHealth downgraded to Neutral from Outperform at Baird 11:03 Today Canaccord Charges against McGee not related to AdaptHealth, says Canaccord 10:35 Today Stifel Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook 04/12/21 Baird AdaptHealth price target raised to $49 from $47 at Baird AHCO AdaptHealth / + 03/04/21 AdaptHealth raises FY21 revenue view to $2.18B-$2.35B from $2.05B-$2.2B 03/04/21 AdaptHealth reports Q4 EPS (47c) with charge, consensus 17c 12/01/20 AdaptHealth raises FY21 revenue view to $2.05B-$2.2B from $1.3B-$1.4B 11/04/20 AdaptHealth sees FY21 revenue $1.3B-$1.4B, consensus $1.21B 06 Jan 15 Dec 03 Sep 01 Jul AHCO AdaptHealth / + 12:06 Today Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 AHCO AdaptHealth / + 11/25/20 new option listings on November 25th
Recommendations	Telenet price target lowered to EUR 55 from EUR 60 at Deutsche Bank » 15:00 04/13/21 04/13 15:00 04/13/21 15:00 TLGHY Telenet $20.77 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLGHY Telenet $20.77 / + (+0.00%) 12/08/20 JPMorgan Telenet upgraded to Overweight from Neutral at JPMorgan 11/04/20 UBS Telenet price target lowered to EUR 33 from EUR 41.50 at UBS 10/23/20 Barclays Telenet price target raised to EUR 43 from EUR 40 at Barclays 10/15/20 BofA Telenet upgraded to Buy from Underperform at BofA
Recommendations	Ryanair price target lowered to EUR 17.60 from EUR 18.50 at Deutsche Bank » 14:59 04/13/21 04/13 14:59 04/13/21 14:59 RYAAY Ryanair $105.83 / -0.13 (-0.12%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals RYAAY Ryanair $105.83 / -0.13 (-0.12%) 01/27/21 Ryanair selects Plurasight Flow to optimize speed, workflows of engineering team 12/27/20 Fly Intel: Top five weekend stock stories 12/03/20 Boeing confirms order for 75 additional 737 MAX airplanes from Ryanair 12/03/20 Ryanair hopes to take delivery of at least 50 MAX aircraft in 2021 RYAAY Ryanair $105.83 / -0.13 (-0.12%) 04/12/21 HSBC Ryanair downgraded to Hold on U.K. reopening plans at HSBC 04/12/21 HSBC Ryanair downgraded to Hold from Buy at HSBC 04/07/21 AlphaValue Ryanair downgraded to Add from Buy at AlphaValue 03/30/21 Berenberg Ryanair upgraded to Buy from Hold at Berenberg RYAAY Ryanair $105.83 / -0.13 (-0.12%) 03/24/21 Ryanair CEO urges tourists to book foreign vacations, Reuters says 12/26/20 Delta, Southwest among airline stocks that could cruise higher, Barron's says 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says

Periodicals	South Africa suspends rollout of Johnson & Johnson vaccine, Bloomberg reports » 14:59 04/13/21 04/13 14:59 04/13/21 14:59 JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) South Africa has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:25 Today Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 07:15 Today J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:34 Today Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 09:48 Today CVS Health tells Bloomberg pausing administration of J&J COVID vaccine 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 12:06 Today Fly Intel: Wall Street's top stories at midday 11:12 Today Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/20/21 Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $159.16 / -2.425 (-1.50%) 09:40 Today Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th
Recommendations	Outokumpu price target raised to EUR 5.70 from EUR 4.30 at Deutsche Bank » 14:58 04/13/21 04/13 14:58 04/13/21 14:58 OUTKY Outokumpu $3.07 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OUTKY Outokumpu $3.07 / + (+0.00%) 05:21 Today AlphaValue Outokumpu upgraded to Reduce from Sell at AlphaValue 03/24/21 Morgan Stanley Outokumpu upgraded to Overweight from Equal Weight at Morgan Stanley 03/22/21 Kepler Cheuvreux Outokumpu upgraded to Buy from Reduce at Kepler Cheuvreux 02/05/21 JPMorgan Outokumpu price target raised to EUR 5.30 from EUR 4.90 at JPMorgan
Recommendations	Swedbank price target raised to SEK 196 from SEK 188 at Deutsche Bank » 14:58 04/13/21 04/13 14:58 04/13/21 14:58 SWDBY Swedbank $18.55 / +0.085 (+0.46%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SWDBY Swedbank $18.55 / +0.085 (+0.46%) 04/12/21 UBS Swedbank price target raised to SEK 175 from SEK 170 at UBS 03/09/21 Barclays Swedbank price target raised to SEK 190 from SEK 172 at Barclays 02/16/21 JPMorgan Swedbank downgraded to Neutral from Overweight at JPMorgan 02/16/21 Deutsche Bank Swedbank downgraded to Hold from Buy at Deutsche Bank
Recommendations	Svenska Handelsbanken price target raised to SEK 118 at Deutsche Bank » 14:57 04/13/21 04/13 14:57 04/13/21 14:57 SVNLY Svenska Handelsbanken $5.64 / +0.035 (+0.62%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SVNLY Svenska Handelsbanken $5.64 / +0.035 (+0.62%) 04/12/21 Barclays Svenska Handelsbanken price target raised to SEK 112 from SEK 105 at Barclays 04/01/21 UBS Svenska Handelsbanken price target raised to SEK 92 from SEK 89 at UBS 03/08/21 Morgan Stanley Svenska Handelsbanken price target raised to SEK 110 at Morgan Stanley 03/04/21 Citi Svenska Handelsbanken upgraded to Neutral from Sell at Citi
Recommendations	Nordea Bank price target raised to EUR 9.10 from EUR 8.60 at Deutsche Bank » 14:57 04/13/21 04/13 14:57 04/13/21 14:57 NRDBY Nordea Bank $10.20 / -0.135 (-1.31%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NRDBY Nordea Bank $10.20 / -0.135 (-1.31%) 04/12/21 Barclays Nordea Bank price target raised to EUR 8.80 from EUR 7.80 at Barclays 04/09/21 UBS Nordea Bank price target raised to SEK 96 from SEK 88 at UBS 03/04/21 JPMorgan Nordea Bank price target raised to SEK 100 from SEK 95 at JPMorgan 02/23/21 Berenberg Nordea Bank price target raised to SEK 90 from SEK 78 at Berenberg

Recommendations	DNB ASA price target raised to NOK 194 from NOK 180 at Deutsche Bank » 14:56 04/13/21 04/13 14:56 04/13/21 14:56 DNHBY DNB ASA $21.38 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DNHBY DNB ASA $21.38 / + (+0.00%) 04/12/21 Barclays DNB ASA price target raised to NOK 142 from NOK 135 at Barclays 03/23/21 UBS DNB ASA price target raised to NOK 143 from NOK 137 at UBS 02/22/21 Keefe Bruyette DNB ASA upgraded to Market Perform from Underperform at Keefe Bruyette 02/17/21 Credit Suisse DNB ASA downgraded to Neutral from Outperform at Credit Suisse
Recommendations	Danske Bank price target raised to DKK 127 from DKK 120 at Deutsche Bank » 14:55 04/13/21 04/13 14:55 04/13/21 14:55 DNKEY Danske Bank $9.93 / +0.09 (+0.91%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DNKEY Danske Bank $9.93 / +0.09 (+0.91%) 04/12/21 Barclays Danske Bank price target raised to DKK 125 from DKK 114 at Barclays 04/12/21 UBS Danske Bank price target raised to DKK 150 from DKK 143 at UBS 02/09/21 Barclays Danske Bank price target raised to DKK 114 from DKK 105 at Barclays 02/08/21 Deutsche Bank Danske Bank price target raised to DKK 120 from DKK 115 at Deutsche Bank
Recommendations	ArcelorMittal price target raised to EUR 30 from EUR 24 at Deutsche Bank » 14:55 04/13/21 04/13 14:55 04/13/21 14:55 MT ArcelorMittal $28.88 / -0.065 (-0.22%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Options MT ArcelorMittal $28.88 / -0.065 (-0.22%) 04/08/21 Infosys announces collaboration with ArcelorMittal 04/01/21 Societe Generale increases shareholding in ArcelorMittal 03/17/21 Air Liquide, ArcelorMittal sign MOU to contribute to decarbonization of Dunkirk 02/11/21 ArcelorMittal CEO to become executive chairman, Aditya Mittal to succeed MT ArcelorMittal $28.88 / -0.065 (-0.22%) 07:06 Today Deutsche Bank ArcelorMittal price target raised to $36 from $30 at Deutsche Bank 04/12/21 UBS ArcelorMittal price target raised to EUR 30 from EUR 25 at UBS 04/09/21 Morgan Stanley ArcelorMittal price target raised to EUR 28.50 from EUR 28 at Morgan Stanley 03/24/21 Morgan Stanley ArcelorMittal price target raised to EUR 28 from EUR 24 at Morgan Stanley MT ArcelorMittal $28.88 / -0.065 (-0.22%) 11/05/20 ArcelorMittal reports Q3 EPS (21c), two estimates (17c) 12 May MT ArcelorMittal $28.88 / -0.065 (-0.22%) 03/24/21 Steel complex lobbies Biden administration on Trump tariffs, Bloomberg says MT ArcelorMittal $28.88 / -0.065 (-0.22%) 04/09/21 Unusually active option classes on open April 9th 04/08/21 Unusually active option classes on open April 8th 04/07/21 ArcelorMittal call volume above normal and directionally bullish 03/31/21 ArcelorMittal call volume above normal and directionally bullish
Conference/Events	William Blair financial services analyst holds analyst/industry conference call » 14:55 04/13/21 04/13 14:55 04/13/21 14:55 ALL Allstate $119.62 / +0.27 (+0.23%) , PGR Progressive $97.63 / +1.275 (+1.32%) , LMND Lemonade $89.14 / -0.63 (-0.70%) , ROOT Root $11.26 / -0.03 (-0.27%) Financial Services &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ALL PGR LMND ROOT ALL Allstate $119.62 / +0.27 (+0.23%) 03/30/21 Synchronoss Personal Cloud selected for integration into Allstate Plans 03/30/21 Allstate agrees to sell ALNY to Wilton Re for $220M 03/22/21 Broadcom, T-Mobile, Linde set to move to S&P 100 at open on 3/22 03/18/21 Hartford Financial jumps after report of Chubb takeover approach PGR Progressive $97.63 / +1.275 (+1.32%) 02/16/21 Progressive to acquire Protective Insurance for $23.30 per share in cash LMND Lemonade $89.14 / -0.63 (-0.70%) 03/02/21 Lemonade falls -10.5% 03/02/21 Lemonade falls -10.0% 01/21/21 Lemonade director sells 65.5K shares of common stock 01/14/21 Lemonade falls -4.9% ROOT Root $11.26 / -0.03 (-0.27%) 03/25/21 Citron's Left says 'makes no sense' Root is being shorted so much 11/06/20 Silver Lake discloses 15.6% stake Root Inc ALL PGR LMND ROOT ALL Allstate $119.62 / +0.27 (+0.23%) 04/12/21 JPMorgan Allstate price target raised to $130 from $127 at JPMorgan 03/31/21 Citi Allstate price target raised to $135 from $128 at Citi 03/30/21 Raymond James Allstate price target raised to $135 from $125 at Raymond James 03/09/21 BofA BofA starts Root at Underperform with $9 price target PGR Progressive $97.63 / +1.275 (+1.32%) 03/18/21 Edward Jones Progressive upgraded to Buy from Hold at Edward Jones 03/09/21 BofA BofA starts Root at Underperform with $9 price target 02/01/21 Deutsche Bank Progressive price target lowered to $105 from $108 at Deutsche Bank 01/13/21 Gordon Haskett Allstate lowering auto rates by 5% in several states, says Gordon Haskett LMND Lemonade $89.14 / -0.63 (-0.70%) 03/30/21 Piper Sandler Lemonade price target lowered to $134 from $159 at Piper Sandler 03/09/21 BofA BofA starts Lemonade at Underperform with $29 price target 03/09/21 BofA Lemonade initiated with an Underperform at BofA 03/08/21 Oppenheimer Oppenheimer upgrades Lemonade on valuation, secular tailwinds ROOT Root $11.26 / -0.03 (-0.27%) 03/10/21 Truist Root sees loss ratio improvement coming this year, says Truist 03/10/21 Citi Root price target lowered to $15 from $20 at Citi 03/09/21 BofA BofA starts Root at Underperform with $9 price target 03/09/21 BofA Root initiated with an Underperform at BofA ALL PGR LMND ROOT ALL Allstate $119.62 / +0.27 (+0.23%) 02/03/21 Allstate reports Q4 adjusted EPS $5.87, consensus $3.81 02/03/21 Notable companies reporting after market close 11/04/20 Allstate reports Q3 adjusted EPS $2.94, consensus $1.66 11/04/20 Notable companies reporting after market close PGR Progressive $97.63 / +1.275 (+1.32%) 03/17/21 Progressive reports February EPS 60c vs. 11c last year 02/17/21 Progressive reports January EPS 95c vs. 52c last year 01/27/21 Progressive reports December EPS $1.20 vs. 78c last year 01/27/21 Progressive reports Q4 EPS $2.85, consensus $1.66 LMND Lemonade $89.14 / -0.63 (-0.70%) 03/01/21 Lemonade sees FY21 revenue $114M-$117M, consensus $111.33M 03/01/21 Lemonade sees Q1 revenue $21.5M-$22.5M, consensus $22.11M 03/01/21 Lemonade reports Q4 EPS (60c), consensus (64c) 03/01/21 Notable companies reporting after market close ROOT Root $11.26 / -0.03 (-0.27%) 12/01/20 Root reports Q3 EPS ($2.20) vs. ($2.88) last year 14 Jan 28 Oct 02 Jul LMND ROOT LMND Lemonade $89.14 / -0.63 (-0.70%) 01/14/21 Lemonade shares heading back to $100, Citron Research says 01/14/21 Citron cautious on Lemonade, says shares going back to $100 12/31/20 Short seller Friendly Bear sees Lemonade falling '90%+ in short order' ROOT Root $11.26 / -0.03 (-0.27%) 12/03/20 Bear Cave says Root Insurance 'misleading investors and consumers' ALL LMND ROOT ALL Allstate $119.62 / +0.27 (+0.23%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 11/04/20 Fly Intel: After-Hours Movers LMND Lemonade $89.14 / -0.63 (-0.70%) 03/09/21 Tesla upgrade, Best Buy initiation among today's top calls on Wall Street 03/02/21 Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers ROOT Root $11.26 / -0.03 (-0.27%) 03/26/21 Fly Intel: Wall Street's top stories for Friday 03/26/21 Fly Intel: Wall Street's top stories at midday 03/25/21 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: After-Hours Movers 15:30 Today Propery & Casualty Insurance/Consumer 05/06/21 Allstate - ALL 05/07/21 Progressive Corporation 05/25/21 Allstate Corp PGR LMND ROOT PGR Progressive $97.63 / +1.275 (+1.32%) 12/07/20 Early notable gainers among liquid option names on December 7th LMND Lemonade $89.14 / -0.63 (-0.70%) 03/31/21 Largest borrow rate increases among liquid names 03/10/21 Lemonade call volume above normal and directionally bullish 01/22/21 Largest borrow rate increases among liquid names 01/21/21 Largest borrow rate increases among liquid names ROOT Root $11.26 / -0.03 (-0.27%) 03/31/21 Root Inc call volume above normal and directionally bullish 03/26/21 Unusually active option classes on open March 26th 01/08/21 Largest borrow rate increases among liquid names 01/06/21 Largest borrow rate increases among liquid names
Recommendations	Aperam price target raised to EUR 40 from EUR 36 at Deutsche Bank » 14:54 04/13/21 04/13 14:54 04/13/21 14:54 APEMY Aperam $50.39 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research APEMY Aperam $50.39 / + (+0.00%) 03/24/21 Morgan Stanley Aperam price target raised to EUR 42 from EUR 40 at Morgan Stanley 02/12/21 Morgan Stanley Aperam price target raised to EUR 40 from EUR 38 at Morgan Stanley 02/02/21 Morgan Stanley Aperam downgraded to Equal Weight from Overweight at Morgan Stanley 02/02/21 Morgan Stanley Acerinox upgraded to Overweight from Equal Weight at Morgan Stanley

Recommendations	Acerinox price target raised to EUR 15 from EUR 14 at Deutsche Bank » 14:54 04/13/21 04/13 14:54 04/13/21 14:54 ANIOY Acerinox $6.75 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ANIOY Acerinox $6.75 / + (+0.00%) 03/24/21 Morgan Stanley Acerinox price target raised to EUR 12.60 from EUR 11.70 at Morgan Stanley 03/08/21 Morgan Stanley Acerinox price target raised to EUR 11.70 from EUR 11 at Morgan Stanley 03/03/21 JPMorgan Acerinox price target raised to EUR 12 from EUR 11.40 at JPMorgan 03/02/21 Credit Suisse Acerinox price target raised to EUR 10 from EUR 9.50 at Credit Suisse
Conference/Events	Senate Commerce, Science & Transportation Committee to hold a hearing » 14:50 04/13/21 04/13 14:50 04/13/21 14:50 MGM MGM Resorts $41.12 / -0.05 (-0.12%) The Subcommittee on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MGM MGM Resorts $41.12 / -0.05 (-0.12%) 04/07/21 MGM Resorts adds enhancements to Convene with Confidence program 04/07/21 New York state budget for fiscal 2022 legalizes mobile sports betting 04/01/21 Macau reports March casino revenue up 58.0% to 8.31B patacas 03/31/21 Detroit Tigers enters sponsorship agreement with BetMGM MGM MGM Resorts $41.12 / -0.05 (-0.12%) 04/07/21 Truist Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud' 04/06/21 Credit Suisse Reports, contacts point to sports betting momentum in NY, Credit Suisse says 04/05/21 Fly Intel: Top five analyst upgrades 04/05/21 Morgan Stanley Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit MGM MGM Resorts $41.12 / -0.05 (-0.12%) 02/10/21 MGM Resorts reports Q4 adjusted EPS (90c), consensus (90c) 02/10/21 Notable companies reporting after market close 10/29/20 MGM Resorts reports Q3 adjusted EPS ($1.08), consensus ($1.04) 10/29/20 Notable companies reporting after market close MGM MGM Resorts $41.12 / -0.05 (-0.12%) 04/06/21 New York to approve online sports betting model backed by Cuomo, Action says 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says MGM MGM Resorts $41.12 / -0.05 (-0.12%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 04/01/21 Macau gaming revenue continues streak, gaining 58% year-over-year in March 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 04/28/21 MGM Resorts - MGM 15:00 Today State of Travel & Tourism During COVID 04/21/21 MGM Resorts 05/05/21 MGM Resorts International MGM MGM Resorts $41.12 / -0.05 (-0.12%) 04/07/21 Call buyer rolls the dice in MGM Resorts 04/05/21 Early notable gainers among liquid option names on April 5th 04/05/21 Unusually active option classes on open April 5th 03/15/21 MGM Resorts call volume above normal and directionally bullish
Options	SeaChange options imply 43.3% move in share price post-earnings » 14:49 04/13/21 04/13 14:49 04/13/21 14:49 SEAC SeaChange $1.41 / -0.06 (-4.08%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events SEAC SeaChange $1.41 / -0.06 (-4.08%) 03/29/21 SeaChange secures multi-million-dollar contract with broadband service in U.S. 02/11/21 SeaChange appoints Matthew Stecker to board of directors 01/13/21 SeaChange appoint Robert Pons as executive chairman, initiates CEO search SEAC SeaChange $1.41 / -0.06 (-4.08%) 09/09/20 Lake Street SeaChange price target lowered to $2 from $4 at Lake Street 30 Mar SEAC SeaChange $1.41 / -0.06 (-4.08%) 03/30/21 Fly Intel: Pre-market Movers 17:00 Today SeaChange - SEAC
Hot Stocks	FDA grants accelerated approval to Trodelvy for advanced urothelial cancer » 14:40 04/13/21 04/13 14:40 04/13/21 14:40 GILD Gilead $64.54 / -0.09 (-0.14%) The FDA has granted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GILD Gilead $64.54 / -0.09 (-0.14%) 04/08/21 Galapagos Gilead extend lock-up period to 2024 04/07/21 Gilead's Trodelvy approved by FDA in TNBC 04/07/21 FDA grants regular approval to Trodelvy for triple-negative breast cancer 04/07/21 FDA grants regular approval to sacituzumab govitecan GILD Gilead $64.54 / -0.09 (-0.14%) 04/01/21 Fly Intel: Top five analyst upgrades 04/01/21 Bernstein Gilead upgraded to Outperform from Market Perform at Bernstein 03/30/21 Redburn Gilead upgraded to Buy from Neutral at Redburn 03/15/21 Mizuho Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho GILD Gilead $64.54 / -0.09 (-0.14%) 02/04/21 Gilead sees FY21 adjusted EPS $6.75-$7.45, consensus $6.85 02/04/21 Gilead reports Q4 adjusted EPS $2.19, consensus $2.15 02/04/21 Notable companies reporting after market close 01/11/21 Gilead raises FY20 adjusted EPS view to $6.98 - $7.08 from $6.25 - $6.60 GILD Gilead $64.54 / -0.09 (-0.14%) 03/15/21 Gilead, Merck to develop long-acting HIV therapy treatment, WSJ reports 11/19/20 WHO urges doctors not to use Gilead's remdesivir for coronavirus, Bloomberg says 10/15/20 WHO study says Gilead's remdesivir has little impact on COVID mortality, FT says GILD Gilead $64.54 / -0.09 (-0.14%) 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday 02/04/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Pre-market Movers 05/12/21 Gilead Sciences Inc. GILD Gilead $64.54 / -0.09 (-0.14%) 03/04/21 Gilead call volume above normal and directionally bullish 01/19/21 Early notable gainers among liquid option names on January 19th 01/11/21 Gilead call volume above normal and directionally bullish 12/31/20 Unusually active option classes on open December 31st
Recommendations	Turkiye Vakiflar price target lowered to TRY 5.10 from TRY 6 at JPMorgan » 14:34 04/13/21 04/13 14:34 04/13/21 14:34 TKYVY Turkiye Vakiflar $4.30 / + (+0.00%) JPMorgan analyst Samuel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TKYVY Turkiye Vakiflar $4.30 / + (+0.00%) 02/10/21 JPMorgan Turkiye Vakiflar price target lowered to TRY 6 from TRY 9.30 at JPMorgan 01/20/21 JPMorgan Turkiye Vakiflar price target lowered to TRY 9.30 from TRY 9.60 at JPMorgan 09/22/20 JPMorgan Turkiye Vakiflar price target raised to TRY 7.60 from TRY 6 at JPMorgan 05/22/20 JPMorgan Turkiye Vakiflar price target raised to TRY 5 from TRY 4 at JPMorgan

Events

Earnings calls, analyst events, roadshows and more

Today at 15:15

Fed Reserve Bank President Delivers Closing Remarks Government Event

Virtual Event
CHNG
Today at 15:30

Change Healthcare Inc. Firm Sponsored Meetings
ALL ...
Today at 15:30

Propery & Casualty Insurance/Consumer Industry Meetings
Today at 16:00

Closed Board Meeting Government Event

Virtual Meeting
FANG
Today at 16:00

Diamondback Energy - FANG Conference Calls
PCYO
Today at 16:30

Pure Cycle - PCYO Conference Calls
AVO
Today at 16:30

Mission Produce, Inc. Firm Sponsored Meetings
LKFN
Today at 16:30

Lakeland Financial Corporation Firm Sponsored Meetings
KRUS
Today at 17:00

Kura Sushi - KRUS Conference Calls
SEAC
Today at 17:00

SeaChange - SEAC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Kadant management to meet virtually with Barrington

TODAY'S FREE FLY STORIES

Get Full Fly Access